FindTrial
Sign In

Omega-3 Fatty Acid Supplement

DIETARY_SUPPLEMENT6 trials

Sponsors

University of Texas Southwestern Medical Center, Sunnybrook Health Sciences Centre, Ohio State University Comprehensive Cancer Center, McMaster University, University of Michigan Rogel Cancer Center

Conditions

AnosmiaBreast CancerCoronary Artery DiseaseCovid19DepressionDry Eye SyndromeEating DisorderRecurrent Breast Cancer

Phase 2

Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
CompletedNCT04268134
University of Michigan Rogel Cancer CenterBreast Cancer
Start: 2020-07-28End: 2024-02-27Updated: 2024-02-29
COVID-19 Anosmia Study
CompletedNCT04495816
Icahn School of Medicine at Mount SinaiAnosmia, Covid19
Start: 2020-07-15End: 2021-12-31Updated: 2023-10-23

Phase 3

Treating Depression in Coronary Artery Disease With Omega-3 Fatty Acids
CompletedNCT00981383
Sunnybrook Health Sciences CentreCoronary Artery Disease, Depression
Start: 2010-06-30End: 2016-05-31Updated: 2017-04-28

Unknown Phase

A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
CompletedNCT00344721
University of Texas Southwestern Medical CenterDry Eye Syndrome
Start: 2004-09-30End: 2008-10-31Updated: 2018-05-14
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
CompletedNCT01478477
Ohio State University Comprehensive Cancer CenterRecurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer +4
Start: 2011-10-04End: 2014-01-09Updated: 2023-02-27
Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders
CompletedNCT01985178
McMaster UniversityEating Disorder
Start: 2013-10-31End: 2016-08-31Updated: 2020-12-22

Related Papers

Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.
2020-11-2313 citations
Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease
Journal of the American Heart Association2018-05-0514 citations
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease Patients.
2017-11-027 citations
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients
Brain Behavior and Immunity2016-10-1538 citations
P1‐060: Oxidative Stress Severity Predicts Omega‐3 Fatty Acid Treatment Efficacy for Immediate Recall in Coronary Artery Disease
Alzheimer s & Dementia2016-07-01
Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study
Neuropsychiatric Disease and Treatment2015-09-0119 citations
Abstract P1-09-03: Prevention of aromatase Inhibitor (AI)-induced joint symptoms with omega-3 fatty acid supplementation: A randomized placebo-controlled pilot study
Cancer Research2015-05-012 citations